"It's time!": A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C
- PMID: 34058670
- DOI: 10.1016/j.drugpo.2021.103280
"It's time!": A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C
Abstract
Background: In Australia, the unrestricted and subsidised availability of direct-acting antivirals for people living with hepatitis C has made the elimination of hepatitis C possible. Recent declining treatment uptake, however, may jeopardise the attainment of this goal. Notification data already exist in many jurisdictions but are presently under-utilised. Despite growing interest in the potential use of data to link people diagnosed with hepatitis C to treatment services, little evidence exists on the acceptability and feasibility of this approach. Our study aimed to address this gap and guide future strategies to enhance treatment uptake.
Methods: Twenty-seven people with lived experience of injecting drug use and/or hepatitis C participated in two focus groups exploring views on implementing a system of hepatitis C notification follow-up in Australia, that would direct people to treatment and care. Additionally, qualitative interviews were conducted with 20 key informants to examine the ethical, logistical, and regulatory implications of implementation. Data were thematically analysed using the Theoretical Framework of Acceptability - which has been used to assess the acceptability of interventions from the perspectives of intervention deliverers and recipients.
Results: While there were clear reservations, there was consensus that the potential benefits of using notification data to contact people with hepatitis C, outweigh harms. The method of contact (including by whom and how), whether follow-up should include recent versus historical diagnoses, and if record linkage should be used to enhance follow-up were important considerations. Ethical and logistical concerns were raised about the risk that such an approach could exacerbate stigma and discrimination.
Conclusion: Findings highlight potentially significant benefits of using notifications data to increase access to hepatitis C treatment, a novel approach that can contribute to hepatitis C elimination efforts and prevent hepatitis C-related morbidity and mortality.
Keywords: Australia; Elimination; HCV surveillance; Hepatitis C; Injecting drug use; Notification systems.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declarations of Interest The author(s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.BMJ Open. 2022 Mar 25;12(3):e056120. doi: 10.1136/bmjopen-2021-056120. BMJ Open. 2022. PMID: 35338062 Free PMC article.
-
Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners.Int J Drug Policy. 2023 Nov;121:104184. doi: 10.1016/j.drugpo.2023.104184. Epub 2023 Sep 13. Int J Drug Policy. 2023. PMID: 37714008 Clinical Trial.
-
Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.Aliment Pharmacol Ther. 2019 May;49(9):1223-1229. doi: 10.1111/apt.15210. Epub 2019 Mar 25. Aliment Pharmacol Ther. 2019. PMID: 30908706
-
Elimination of Hepatitis C Virus in Australia: Laying the Foundation.Infect Dis Clin North Am. 2018 Jun;32(2):269-279. doi: 10.1016/j.idc.2018.02.006. Infect Dis Clin North Am. 2018. PMID: 29778255 Review.
-
Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.J Viral Hepat. 2020 Dec;27(12):1270-1283. doi: 10.1111/jvh.13399. Epub 2020 Sep 22. J Viral Hepat. 2020. PMID: 32964615 Free PMC article. Review.
Cited by
-
The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People 'Lost to Follow Up'.Public Health Ethics. 2024 May 17;17(1-2):40-52. doi: 10.1093/phe/phae006. eCollection 2024 Apr-Jul. Public Health Ethics. 2024. PMID: 39005529 Free PMC article.
-
A pilot project harnessing surveillance systems to support clinicians providing clinical care for people diagnosed with hepatitis C in Victoria, Australia, September 2021 to 31 March 2022.Euro Surveill. 2024 Jul;29(29):2400028. doi: 10.2807/1560-7917.ES.2024.29.29.2400028. Euro Surveill. 2024. PMID: 39027939 Free PMC article.
-
Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.BMJ Open. 2022 Mar 25;12(3):e056120. doi: 10.1136/bmjopen-2021-056120. BMJ Open. 2022. PMID: 35338062 Free PMC article.
-
Injection drug use in an affluent beachside community in Sydney: An exploratory qualitative study.Drug Alcohol Rev. 2023 Mar;42(3):544-554. doi: 10.1111/dar.13592. Epub 2022 Dec 20. Drug Alcohol Rev. 2023. PMID: 36539306 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous